3D printing has made its biggest impact in manufacturing, and increasingly in recent years it has shown its potential in the medical field, as it is used in the development of prosthetics, replacement organs and medical equipment.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, chair of the Urology Trade Association, fellow of the Royal Society of Medicine and trustee of the Institute of Medical Ethics, marks Urology Awareness Month and highlights t
Cleanrooms kits—such as Connect 2 Cleanrooms’ (C2C) ready-to-ship range of Rapid Room cleanrooms—offer organisations a quick way of adding additional cleanroom space and they are gaining in popularity.
ENGEL discusses how integrated solution can boost efficiency and how automated production of ophthalmic products can be done in the smallest possible work area.
Tom Bouchier, managing director of robotics and automation specialist FANUC UK, explains, there has never been a better time for UK firms to invest in automation. Here, Tom outlines the key changes within the automation landscape.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, chair of the Urology Trade Association, Fellow of the Royal Society of Medicine and Trustee of the Institute of Medical Ethics, updates on a series of senior appointments and
Ian Bolland spoke to Stephen Cartwright, Government of New South Wales agent general to the United Kingdom senior trade & investment commissioner for Europe & Israel about the attractive nature of the region for life sciences.
Eric Erickson from Stratasys explains the value of increased personalisation within healthcare, the state of the industry including the main barriers to adoption as well as recent innovative developments in 3D printing materials.
Chris Whitehouse, an expert on medical technology policy and regulation at Whitehouse Communications and chair of the Urology Trade Association, provides his thoughts on the published consultation from the MHRA about medical device regulation in the UK. In the small hours of the night, on Sunday 26t
Vertellus shares insight on Hollow Fibre Membranes (HFM) in biopharmaceuticals and how it became a crucial part of the biotech industry’s value chain in recent years.
Carolina Acosta and Lodovico Agostinis, chemical technology group researchers, explain AIMPLAS’ project to develop improved PPE using antimicrobial materials.
